arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Cingulate Inc.

CING Health Care Biotechnology: Pharmaceutical Preparations
$4.70
▲ +0.9% Today
as of Oct 23, 14:16 ET
Last 30 days -7.70% Sep 14 → Oct 23
$4.29 $4.54 $4.80 $5.06 $5.31 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$4.60
High
$4.82
Low
$4.60
Volume
$77,949
Avg Vol
$331,610
Mkt Cap
$69M
P/E (TTM)
—
Beta
—
52w High
$11.89
52w Low
$3.16
Div Yield
—
Shares Out
$14M

Recent Press Releases & News last 60 days · 1 item

Sep 17 · 12:05 PR GlobeNewswire
Shane Schaffer, Cingulate Chairman & CEO to Present “SMART Launch” Approach at Indegene Digital Summit: Rethinking Commercialization for Emerging Pharma

CING earnings at a glance

The options market is pricing a move of about ±18.4% after the report, a range of roughly $3.83 to $5.57 from today's $4.70. Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±7.3% on average; after the most recent report on May 14, 2026 it moved -10.8%. That means options currently expect more movement than CING has typically delivered. CING beat the consensus EPS estimate in 0 of its last 4 reported quarters. Implied volatility is currently 156%. The share price of $4.70 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$3.16
$12
18% of range
Avg surprise (last 4)
-46.2%
Avg reaction (last 2)
-3.5%
50% positive
Latest IV / EM
156%
EM ±18.4% · $5 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-72.60$-54.20$-35.80$-17.40$1.00 Actual $-7.08Actual $-6.79Actual $-72.60Actual $-7.21Actual $-5.47Actual $-2.34Actual $-1.04Est $1.00Actual $-1.09Est $-0.82Actual $-1.35Est $-0.80Actual $-0.95Est $-0.53Actual $-0.45 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-9M$-8M$-7M$-5M$-4M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.45 — — — — financials
Thu May 14, 2026Mar/2026 $-0.95 $-0.53 -79.2% +8.7% -10.8% earnings
Thu Nov 13, 2025Sep/2025 $-1.35 $-0.80 -68.8% — — earnings
Tue Aug 19, 2025Jun/2025 $-1.09 $-0.82 -32.9% — — earnings
Thu May 8, 2025Mar/2025 $-1.04 $1.00 -4.0% — +3.8% earnings
Mon Sep 30, 2024Sep 2024 $-2.34 — — — — financials
Sun Jun 30, 2024Jun 2024 $-5.47 — — — — financials
Sun Mar 31, 2024Mar 2024 $-7.21 — — — — financials
Sat Sep 30, 2023Sep 2023 $-72.60 — — — — financials
Fri Jun 30, 2023Jun 2023 $-6.79 — — — — financials
Fri Mar 31, 2023Mar 2023 $-7.08 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue————————
Cost of revenue————————
Gross profit————————
Operating income$-5M$-8M—$-6M$-5M$-4M—$-3M
Net income$-6M$-9M—$-7M$-5M$-4M—$-4M
EPS (diluted)$-0.45$-0.95—$-1.35$-1.14$-1.06—$-2.34

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$28M$26M$11M$6M$9M$10M$12M$10M
Inventory————————
Total current assets$30M$28M$12M$7M$10M$11M$13M$11M
Total assets$33M$31M$15M$11M$13M$12M$15M$14M
Long-term debt————————
Total liabilities$10M$12M$13M$7M$8M$7M$7M$2M
Total equity$23M$19M$3M$3M$6M$6M$7M$12M

Implied volatility — last 90 days

61%511%962%1412%1862% Jun 07 — IV 217% · EM ±30.0%Jun 08 — IV 247% · EM ±32.6%Jun 09 — IV 240% · EM ±30.1%Jun 10 — IV 229% · EM ±27.1%Jun 11 — IV 253% · EM ±27.9%Jun 12 — IV 170% · EM ±17.4%Jun 15 — IV 182% · EM ±13.2%Jun 16 — IV 205% · EM ±12.1%Jun 17 — IV 293% · EM ±12.3%Jun 19 — IV 202% · EM ±44.6%Jun 22 — IV 158% · EM ±32.9%Jun 23 — IV 164% · EM ±33.6%Jun 24 — IV 189% · EM ±37.9%Jun 25 — IV 201% · EM ±39.4%Jun 26 — IV 152% · EM ±29.1%Jun 29 — IV 175% · EM ±31.0%Jun 30 — IV 331% · EM ±56.9%Jul 01 — IV 223% · EM ±37.2%Jul 02 — IV 152% · EM ±24.6%Jul 03 — IV 158% · EM ±24.6%Jul 06 — IV 163% · EM ±22.6%Jul 07 — IV 267% · EM ±35.3%Jul 08 — IV 206% · EM ±25.8%Jul 09 — IV 171% · EM ±20.2%Jul 10 — IV 74% · EM ±8.1%Jul 13 — IV 64% · EM ±5.3%Jul 14 — IV 308% · EM ±22.3%Jul 15 — IV 1863% · EM ±110.0%Jul 16 — IV 757% · EM ±31.6%Jul 20 — IV 274% · EM ±64.7%Jul 21 — IV 97% · EM ±22.5%Jul 22 — IV 108% · EM ±24.8%Jul 23 — IV 282% · EM ±63.5%Jul 24 — IV 168% · EM ±37.2%Jul 27 — IV 124% · EM ±26.0%Jul 28 — IV 100% · EM ±20.4%Jul 29 — IV 116% · EM ±23.2%Jul 30 — IV 115% · EM ±22.6%Jul 31 — IV 123% · EM ±23.5%Aug 03 — IV 216% · EM ±38.3%Aug 04 — IV 116% · EM ±19.9%Aug 05 — IV 82% · EM ±13.7%Aug 06 — IV 61% · EM ±9.9%Aug 07 — IV 605% · EM ±94.6%Aug 10 — IV 151% · EM ±21.0%Aug 11 — IV 127% · EM ±16.8%Aug 12 — IV 70% · EM ±8.8%Aug 13 — IV 110% · EM ±13.0%Aug 24 — IV 167% · EM ±34.9%Aug 25 — IV 162% · EM ±33.2%Aug 26 — IV 148% · EM ±29.6%Aug 27 — IV 174% · EM ±34.0%Aug 28 — IV 108% · EM ±20.7%Aug 31 — IV 450% · EM ±79.7%Sep 01 — IV 456% · EM ±78.5%Sep 03 — IV 130% · EM ±21.1%Sep 04 — IV 91% · EM ±14.2%Sep 07 — IV 103% · EM ±14.2%Sep 08 — IV 153% · EM ±20.2%Sep 09 — IV 176% · EM ±22.1%Sep 10 — IV 196% · EM ±23.2%Sep 11 — IV 144% · EM ±15.9%Sep 14 — IV 857% · EM ±71.6%Sep 15 — IV 257% · EM ±18.6%Sep 16 — IV 116% · EM ±6.9%Sep 17 — IV 1689% · EM ±70.5%Sep 21 — IV 89% · EM ±18.6%Sep 22 — IV 446% · EM ±91.4%Sep 23 — IV 110% · EM ±22.1%Sep 24 — IV 126% · EM ±24.7%Sep 25 — IV 70% · EM ±13.5%Sep 28 — IV 146% · EM ±25.9%Sep 30 — IV 472% · EM ±78.8%Oct 08 — IV 156% · EM ±18.4%

Sector peers

CTOR
Citius Oncology, Inc.
$71M $0.66-5.6%
MAIA
MAIA Biotechnology, Inc.
$73M $1.14+0.1%
HRTX
Heron Therapeutics, Inc.
$73M $0.29-13.6%
LFVN
Lifevantage Corporation
$76M $5.61-5.7%
BOLD
Boundless Bio, Inc.
$60M $2.38-2.7%
TELO
Telomir Pharmaceuticals, Inc.
$80M $0.97-4.4%

CING earnings FAQ

What is CING's expected move for earnings?

Options currently price a move of about ±18.4%, or $0.87 per share either way from $4.70.

How does CING stock usually react to earnings?

Across the last 2 reports the average next-day move was ±7.3%, up 1 times and down 1 times.

What is CING's implied volatility?

CING's at-the-money implied volatility is about 156% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in